Karpus WJ, Kennedy KJ, Fife BT, Bennett JL, Dal Canto MC, Kunkel SL, Lukacs NW. (2006). "Anti-CCL2 treatment inhibits Theiler’s marine encephalomyelitis virus-induced demyelinating disease." Journal of Neurovirology  Volume 12, Number 4, pp. 251-261.

W.J. Karpus, B.T. Fife, and K.J. Kennedy.  2003.  “Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease.” Methods Volume 29, Number 4, 362-368.

Elhofy, A, K.J. Kennedy, B.T. Fife, and W.J. Karpus.  2002. “Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors.” Immunology Research Volume 25, Number 2, 167-175.

Fife, B.T., K.J. Kennedy, M. Paniagua, N.W. Lukacs, S.L. Kunkel, A.D. Luster, and W.J.Karpus.  2001.  “CXCL10 (IFN--inducible protein-10) control of encephalitogenic CD4⁺ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.”  Journal of Immunology, Volume 166, 7617-24

Kennedy, K.J., and W.J. Karpus.  1999.  “Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis.”  Journal of Clinical Immunology, Volume 19, Number 5, 273-279.

Karpus, W.J., K.J. Kennedy, B.T. Fife, and L.M. Hoffman. 1999. “Chemokine regulation of immune-mediated demyelinating disease.”  ILAR Journal, Volume 40, 183-189.

Kennedy, K.J., R.M. Strieter, S.L. Kunkel, N.W. Lukacs, and W.J. Karpus.  1998. “Acute and relapsing autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1 alpha and monocyte chemotactic protein-1.”  Journal of Neuroimmunology, Volume 92, 98-108.

Karpus, W.J., K.J. Kennedy, S.L. Kunkel, and N.W. Lukacs.  1998.  “Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.”  Journal of Experimental Medicine, Volume 187, 733-41.

Karpus, W.J., and K.J. Kennedy.  1997.  “MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 differentiation.”  Journal of Leukocyte Biology, Volume 62, Number 5, 681-687.

Kennedy, K.J., W.S. Smith, S.D. Miller, and W.J. Karpus.  1997.  “Induction of antigen    specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis.  A comparison between oral and peripheral tolerance.” Journal of Immunology, Volume 159, 1036-1044.

Karpus, W.J., N.W. Lukacs, K.J. Kennedy, W.S. Smith, S.D. Hurst, and T.A. Barrett. 1997.  “Differential CC chemokine-induced enhancement of T helper cell cytokine production.”  Journal of Immunology, Volume 158, 4129-4136.

Karpus, W.J., K.J. Kennedy, W.S. Smith, and S.D. Miller.  1996.  “Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP 139-151 peptide.”  Journal of Neuroscience Research. Volume 45, 410-423.

Whitman, R.L., A.V. Gochee, W.A. Dustman, and K.J. Kennedy.  1995.  “Use of coliform bacteria in assessing human sewage contamination.”  Natural Areas Journal, Volume 15, 227-233.

Whitman, R.L., M.C. Andrzejewski, K.J. Kennedy, and T.A. Sobat.  1994.  “Composition, spacial-temporal distribution, and environmental factors influencing the interstitial beach meiofauna of southern Lake Michigan.  Verhandlungen Internationale Vereinigung für Theoretische und Angewandte Limnologie.”  Proceedings of the International Association for Theoretical and Applied Limnology  Volume 25, 1389-1397.